Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2021-11-15 , DOI: 10.1111/apt.16700
Mariangela Allocca ₁ , Vincenzo Craviotto ₂ , Cecilia Dell'Avalle ₂ , Federica Furfaro ₂ , Alessandra Zilli ₁ , Ferdinando D'Amico _{1,

3} , Stefanos Bonovas _{2,

3} , Laurent Peyrin-Biroulet ₄ , Gionata Fiorino _{2,

3} , Silvio Danese ₁

Affiliation

We developed a non-invasive bowel ultrasound score (BUSS) to assess disease activity in Crohn’s disease (CD). BUSS >3.52 is an indicator of endoscopic activity (SES-CD>2).

中文翻译：